Skip to content
Screener

Charles River Laboratories CRL Finite-Lived Intangible Assets, Accumulated Amortization

Finite-Lived Intangible Assets, Accumulated Amortization at other companies

Labcorp Holdings logo
Labcorp HoldingsLH
NeoGenomics logo
NeoGenomicsNEO

Other financials

Income statement

See full
Revenue$1.0B-2.7%
Gross profit$349.0M-3.5%
Operating income$119.9M+19.7%
Net income-$1.5M-103%
EPS (diluted)-$0.03-103%

Balance sheet

See full
Cash & equivalents$240.6M+30.2%
Total debt$3.0B+8.1%
Total equity$2.8B-15.3%
Total assets$7.5B-0.4%

Cash flow

See full
Operating cash flow$179.7M-12.2%
CapEx$31.1M-11.9%
Free cash flow$148.6M-12.2%

Valuation

See full
Market cap$12.77B+74.2%
Enterprise value$15.57B+56.4%
P/S3.2×+1.4×

Profitability

See full
Gross margin84.7%
Operating margin13%-2.4pp
Net margin-6%
FCF margin9.3%-5.1pp

Returns & leverage

See full
Return on equity-7.7%
Debt / equity1.1×+0.2×
Current ratio1.3×0.0×

Where this comes from

Reported directly by Charles River Laboratories in its filing.

Tagged under the XBRL concept us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization.

The source filing: Charles River Laboratories’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 9:21 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001100682-26-000118
Line itemJune 27, 2026 / GrossJune 27, 2026 / Accumulated AmortizationJune 27, 2026 / NetDecember 27, 2025 / GrossDecember 27, 2025 / Accumulated AmortizationDecember 27, 2025 / Net
Client relationships$899,325$(679,409)$219,916$1,325,779$(1,016,198)$309,581
Technology130,650(107,075)23,575142,084(124,172)17,912
Trademarks and trade names4,703(3,367)1,3368,882(6,869)2,013
Other18,164(9,817)8,34721,052(10,563)10,489
Intangible assets$1,052,842$(799,668)$253,174$1,497,797$(1,157,802)$339,995

Item 1. Financial Statements

FAQ

What is Charles River Laboratories's finite-lived intangible assets, accumulated amortization?
Charles River Laboratories (CRL) reported finite-lived intangible assets, accumulated amortization of $799.67M in Q2 2026.
How has Charles River Laboratories's finite-lived intangible assets, accumulated amortization changed year-over-year?
Charles River Laboratories's finite-lived intangible assets, accumulated amortization decreased by 28.0% year-over-year, from $1.11B to $799.67M.
What is the long-term trend for Charles River Laboratories's finite-lived intangible assets, accumulated amortization?
Over 5 years (2020 to 2025), Charles River Laboratories's finite-lived intangible assets, accumulated amortization has grown at a 16.2% compound annual growth rate (CAGR), from $546.65M to $1.16B.
What does finite-lived intangible assets, accumulated amortization mean?
Finite-Lived Intangible Assets, Accumulated Amortization

Ask your AI about Charles River Laboratories's finite-lived intangible assets, accumulated amortization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude